Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines

Published:2015-10 Issue: Volume: Page:1575
ISSN:1178-1998
Container-title:Clinical Interventions in Aging
language:en
Short-container-title:CIA

Author:

Omboni Stefano,Malacco Ettore,Mallion Jean-Michel,Volpe Massimo

Publisher

Informa UK Limited

Subject

Geriatrics and Gerontology,General Medicine

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of sacubitril/valsartan with olmesartan for hypertension: A meta-analysis of randomized controlled trials;Medicine;2024-04-05

2. Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan;Advances in Therapy;2018-12-27

3. Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double-blind, 8-week study;The Journal of Clinical Hypertension;2018-01

4. Blood pressure response to metoprolol and chlorthalidone in European and African Americans with hypertension;The Journal of Clinical Hypertension;2017-09-21

5. Blood pressure targets for hypertension in older adults;Cochrane Database of Systematic Reviews;2017-08-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP